We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
Uniquement les titres à fort signal — événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Chipotle Mexican Grill Inc (NYSE:CMG) is one of the best large cap stocks to buy in 2026 according to billionaire Dan Loeb. The Street sees Chipotle stock gaining more than 30% over the next 12 months. On May 4, Argus upgraded Chipotle’s stock rating to Buy from Hold and set a price target of $40. […]
It's still a no-go on these items at Chipotle.
<body><p>STORY: Shares of Shake Shack plunged as much as 30% on Thursday and were heading for their worst day ever after the restaurant chain reported a quarterly profit loss and missed Wall Street's revenue estimates.</p><p>Shake Shack said it was hurt by rising commodity costs, including beef, and weak consumer spending.</p><p>And it's not the only fast‑food chain seeing consumers tighten their belts.</p><p>McDonald's, Domino's and Papa John's all reported weaker quarterly sales growth, signaling pressure on consumer spending from rising gas prices driven by the U.S. war in Iran.</p><p>Companies like Chipotle and Restaurant Brands International have also flagged rising beef prices, which have set records due to dwindling U.S. cattle supplies.</p><p>Shake Shack executives said on a post-earnings call that the company's short-term results will continue to be impacted by the ongoing war in the Middle East.</p></body>
Guggenheim trimmed its price target on Chipotle Mexican Grill (NYSE:CMG) to $35 from $36 on Friday, keeping a Neutral rating as margin pressure forces earnings estimate cuts. Analyst Gregory Francfort lowered both 2026 and 2027 earnings per share (EPS) estimates by about 3%, signaling that profitability headwinds may outlast any near-term traffic recovery. For prudent ... Guggenheim Cuts Chipotle Price Target as Margin Pressure Mounts: Is the Recovery Story Stalling?